Home › Funds › PSP Research LLC › EXEL
PSP Research LLC position in EXEL
EXELIXIS INC · Health Care
PSP Research LLC reported holding 5,000 shares of EXEL (EXELIXIS INC) in its Q3 2026 13F filing — a position valued at US$292K, representing 0.20% of its reported portfolio and ranking #6 among its reported holdings. PSP Research LLC has disclosed EXEL holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR
How PSP Research LLC's EXEL position evolved
PSP Research LLC first disclosed a stake in EXEL in Q4 2025 at 11,948 shares (US$524K). Across 4 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 5,000 shares valued at US$292K — a reduction of -3,000 shares quarter over quarter.. Notable position changes include a 33% trim in Q2 2026 (shares rose 6% over the following quarter), a 38% trim in Q3 2026 (shares rose 24% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 11.95K | $523.68K | New |
| Q1 2026 | 11.95K | $512.45K | Hold |
| Q2 2026 | 8.00K | $435.28K | Reduce |
| Q3 2026 | 5.00K | $292.05K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EXEL and 13F data
EXEL (EXELIXIS INC) is a Health Care company. 42 other funds we track also report a position in EXEL — the largest reported positions include Farallon Capital Management (US$732.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$732.8M), Renaissance Technologies (US$730.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EXEL
- Farallon Capital Management 13.47M sh · $732.79M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 13.47M sh · $732.79M · Q2 2026
- Renaissance Technologies 13.43M sh · $730.62M · Q2 2026
- FULLER & THALER ASSET MANAGEMENT, INC. 8.93M sh · $485.85M · Q2 2026
- D. E. Shaw & Co., Inc. 5.55M sh · $302.07M · Q2 2026
- Two Sigma Investments 4.21M sh · $229.06M · Q2 2026
- Stephens Investment Management Group LLC 2.71M sh · $147.45M · Q2 2026
- Caligan Partners LP 1.55M sh · $84.51M · Q2 2026
More on PSP Research LLC
FAQ
How long has PSP Research LLC held EXEL?
PSP Research LLC has disclosed EXEL holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is PSP Research LLC's current position in EXEL?
As of Q3 2026, PSP Research LLC holds 5.00K shares of EXEL (EXELIXIS INC), valued at $292.05K, representing 0.20% of its reported portfolio and ranking #6.
Has PSP Research LLC been buying or selling EXEL?
In the latest 13F filing (Q3 2026), PSP Research LLC reduced its position in EXEL.
Which other funds hold EXEL?
Other major institutional holders of EXEL include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., Renaissance Technologies, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.